Response to exogenous surfactant is different during open lung and conventional ventilation

Critical Care Medicine

Volumn 32, Issue 3, 2004, Pages 774-780

  Van Kaam, Anton H ^a,b   Haitsma, Jack J ^a   Dik, Willem A ^a   Naber, Birgitta A ^a   Alblas, Elise H ^a   De Jaegere, Anne ^b   Kok, Joke H ^b   Lachmann, Burkhard ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

High frequency ventilation; Intermittent positive pressure ventilation; Open lung ventilation; Piglets; Pulmonary surfactants

Indexed keywords

HL 10; INTERLEUKIN 8; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HIGH FREQUENCY OSCILLATION; LUNG LAVAGE; LUNG MECHANICS; LUNG VENTILATION; NEUTROPHIL; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RANDOMIZATION; SWINE; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, NEWBORN; INTERMITTENT POSITIVE-PRESSURE VENTILATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY MECHANICS; SWINE;

EID: 1542509847     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000114578.48244.21     Document Type: Article

References (33)

1. Soll RF: Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000; (2):CD000511
2. Verbrugge SJ, Vazquez DA, Gommers D, et al: Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation-induced lung injury. Anesthesiology 1998; 89:467-474
3. Notter RH, Egan EA, Kwong MS, et al: Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age. Pediatr Res 1985; 19: 569-577
4. Gortner L, Pohlandt F, Bartmann P, et al: High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr 1994; 83:135-141
5. Berry DD, Pramanik AK, Philips JB III, et al: Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II. J Pediatr 1994; 124:294-301
6. Dreyfuss D, Soler P, Basset G, et al: High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137: 1159-1164
7. Taskar V, John J, Evander E, et al: Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 1997; 155:313-320
8. Lachmann B: Open up the lung and keep the lung open. Intensive Care Med 1992; 18: 319-321
9. van Kaam AH, De Jaegere A, Haitsma JJ, et al: Positive pressure ventilation with the open lung concept optimizes gas exchange and reduces ventilator-induced lung injury in newborn piglets. Pediatr Res 2003; 53: 245-253
10. Rimensberger PC, Cox PN, Frndova H, et al: The open lung during small tidal volume ventilation: Concepts of recruitment and "optimal" positive end-expiratory pressure. Crit Care Med 1999; 27:1946-1952
11. Rider ED, Jobe AH, Ikegami M, et al: Different ventilation strategies alter surfactant responses in preterm rabbits. J Appl Physiol 1992; 73:2089-2096
12. Wada K, Jobe AH, Ikegami M: Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997; 83:1054-1061
13. Ito Y, Veldhuizen RA, Yao LJ, et al: Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am J Respir Crit Care Med 1997; 155:493-499
14. Gommers D, Vilstrup C, Bos JA, et al: Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993; 21:567-574
15. Markstaller K, Eberle B, Kauczor HU, et al: Temporal dynamics of lung aeration determined by dynamic CT in a porcine model of ARDS. Br J Anaesth 2001; 87:459-468
16. Veldhuizen RA, Inchley K, Hearn SA, et al: Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 1993; 295:141-147
17. Rouser G, Fkeischer S, Yamamoto A: Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5:494-496
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254
19. Dambrosio M, Fiore G, Brienza N, et al: Right ventricular myocardial function in ARF patients. PEEP as a challenge for the right heart. Intensive Care Med 1996; 22:772-780
20. Bjorklund LJ, Vilstrup CT, Larsson A, et al: Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:918-923
21. Kerr CL, Veldhuizen RA, Lewis JF: Effects of high-frequency oscillation on endogenous surfactant in an acute lung injury model. Am J Respir Crit Care Med 2001; 164: 237-242
22. Verbrugge SJ, Gommers D, Lachmann B: Conventional ventilation modes with small pressure amplitudes and high positive end-expiratory pressure levels optimize surfactant therapy. Crit Care 1999; 27: 2724-2728
23. Lachmann B, Eijking EP, So KL, et al: In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20:6-11
24. Kawano T, Mori S, Cybulsky M, et al: Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987; 62: 27-33
25. Groneck P, Gotze-Speer B, Oppermann M, et al: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates, Pediatrics 1994; 93:712-718
26. Stamme C, Brasch F, von Bethmann A, et al: Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. Pulm Pharmacol Ther 2002; 15: 455-461
27. Ricard JD, Dreyfuss D, Saumon G: Production of inflammatory cytokines in ventilator-induced lung injury: A reappraisal. Am J Respir Crit Care Med 2001; 163:1176-1180
28. Meloni F, Alberti A, Bulgheroni A, et al: Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production. Eur Respir J 2002; 19: 1128-1135
29. Froese AB, McCulloch PR, Sugiura M, et al: Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993; 148:569-577
30. Dreyfuss D, Saumon G: Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323
31. van der Bleek J, Plotz FB, van Overbeek FM, et al: Distribution of exogenous surfactant in rabbits with severe respiratory failure: The effect of volume. Pediatr Res 1993; 34: 154-158
32. Horbar JD (Ed): The Vermont Oxford Network 1999 Database Summary. Burlington, VT, Vermont Oxford Network, 2001
33. Kesecioglu J, Schultz MJ, Lundberg D, et al: Treatment of acute lung injury (ALI/ARDS) with surfactant. Am J Respir Crit Care Med 2001; 163:A819